Agios Pharma (AGIO) Reports In-Line Q1 EPS

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.63), in-line with the analyst estimate of ($1.63). Revenue for the quarter came in at $8.76 million versus the consensus estimate of $10.6 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Turning Point Brands (TPB) PT Lowered to $90 at Oppenheimer
• Here Group posts FY2026 results with $88M revenue, goodwill write-down